Inspire Medical Systems, Inc Sees Prelim. Q4 Revenue $192.3M-$192.5M vs $177.94M Est., Sees FY23 Revenue $624.6M-$624.8M vs $610.22M Est.
Portfolio Pulse from Benzinga Newsdesk
Inspire Medical Systems, Inc. has announced preliminary Q4 revenue between $192.3M and $192.5M, surpassing the estimated $177.94M. Additionally, the company forecasts FY23 revenue to be between $624.6M and $624.8M, which is also above the estimated $610.22M.
January 08, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems, Inc. has reported preliminary Q4 revenues that exceed analyst estimates and provided a higher than expected revenue forecast for FY23.
The positive preliminary Q4 revenue and the optimistic forecast for FY23 suggest strong performance and potential growth for Inspire Medical Systems. This is likely to be viewed favorably by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100